Country: Canada
Language: English
Source: Health Canada
CHLORHEXIDINE GLUCONATE
PENDOPHARM DIVISION OF PHARMASCIENCE INC
A01AB03
CHLORHEXIDINE
0.12%
MOUTHWASH
CHLORHEXIDINE GLUCONATE 0.12%
BUCCAL
475ML
Prescription
MISCELLANEOUS ANTI-INFECTIVES
Active ingredient group (AIG) number: 0107629007; AHFS:
APPROVED
2018-09-04
_ _ _PERICHLOR and PERICHLOR WITHOUT ALCOHOL-Product Monograph _ _Page 1 of 14_ PRODUCT MONOGRAPH PR PERICHLOR ® PR PERICHLOR ® WITHOUT ALCOHOL Chlorhexidine Gluconate Mouthwash 0.12% BP ANTIGINGIVITIS ORAL RINSE PENDOPHARM, DIVISION OF PHARMASCIENCE INC. 6111 Royalmount Ave., Suite 100 Montréal, Canada H4P 2T4 Date of Revision: October 10, 2019 PERICHLOR ® is a registered trademark of Pharmascience Inc. Submission Control No: 223243 _ _ _PERICHLOR and PERICHLOR WITHOUT ALCOHOL-Product Monograph _ _Page 2 of 14_ PR PERICHLOR ® PR PERICHLOR ® WITHOUT ALCOHOL Chlorhexidine Gluconate Mouthwash 0.12% BP ACTIONS, CLINICAL PHARMACOLOGY PERICHLOR and PERICHLOR WITHOUT ALCOHOL (0.12% Chlorhexidine Gluconate Mouthwash) provide antimicrobial activity during oral rinsing which is maintained between rinsings. Microbiologic sampling of plaque has shown a general reduction of both aerobic and anaerobic bacterial counts ranging from 54-97% through six months’ clinical use. Rinsing with PERICHLOR and PERICHLOR WITHOUT ALCOHOL inhibits the buildup and maturation of plaque by reducing certain microbes regarded as gingival pathogens, thereby reducing gingivitis 1,4,5 . Chlorhexidine Gluconate Mouthwash provided antimicrobial activity during rinsing and for several hours thereafter. No significant changes in bacterial sensitivity, overgrowth of potentially opportunistic organisms or other adverse changes in the oral microbial flora were observed following the use of Chlorhexidine Gluconate Mouthwash for six months. Three months after Chlorhexidine Gluconate Mouthwash use was discontinued, the number of bacteria in plaque had returned to pre-treatment levels and sensitivity of plaque bacteria to chlorhexidine gluconate remained unchanged. Studies conducted with human subjects and animals demonstrate that any ingested chlorhexidine gluconate is poorly absorbed from the gastrointestinal tract. Excretion of chlorhexidine gluconate occurred primarily through the feces (approximately 90%). Less than 1% of the chlorhexidine glucona Read the complete document